Switch View
© PR Newswire
10.11.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Queer Eye's Tan France helps unthread obesity bias as part of Zepbound's (tirzepatide) 'Changing the Thread Collection'
News Preview
New innovative campaign weaves science and storytelling to help reframe obesity as a chronic disease
INDIANAPOLIS, Nov. 10, 2025 /PRNewswire/ -- For Tan France, clothing has always been about more than appearance – it's about self-expression. As a stylist and ad...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
Lost Money on MoonLake Immunotherapeutics (MLTX)? Urged to Join Class Action Before December 15, 2025 - Contact Levi & Korsinsky
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ: MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=176446&wire=5&...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
CVS Health to hold Investor Day on December 9, 2025
News Preview
WOONSOCKET, R.I., Nov. 10, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold its Investor Day on December 9th, 2025. Members of management will discuss the Company's strategy and will provide financial guidance for 2025 and 2026....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
10.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. (INSP) Faces Investor Suit Over Disastrous Inspire V Launch-- Hagens Berman
News Preview
SAN FRANCISCO, Nov. 10, 2025 /PRNewswire/ -- Inspire Medical Systems, Inc. (NYSE: INSP) is now grappling with a proposed class-action lawsuit alleging the company misled investors about the commercial readiness and demand for its critical "next generation" sleep apnea device, the Inspire V. The litigation zeroes...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
10.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Wellcare to Offer Medicare Advantage and Medicare Prescription Drug Plans in 205 Texas Counties in 2026
News Preview
In 2026, Wellcare will also expand coverage for individuals who qualify for both Medicare and Medicaid, providing access to more comprehensive care and benefits
AUSTIN, Texas, Nov. 10, 2025 /PRNewswire/ -- Wellcare, Wellcare By Allwell, and Wellcare By Superior...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US71535D1063
Personalis, Inc.
PSNL
LISTED
NASDAQ
Personalis Announces Medicare Coverage for Ultrasensitive MRD Test in Breast Cancer
News Preview
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced Medicare coverage of its ultrasensitive NeXT Personal® test for surveillance of cancer recurrence in breast cancer patients. This milestone marks an important step forward in cancer surveillance, offering a powerful tool for doctors and breast ca...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: CA00288U1066
Abcellera Biologics Inc
ABCL
LISTED
NASDAQ
AbCellera Appoints Dr. Stephen Quake to its Board of Directors
News Preview
AbCellera (Nasdaq: ABCL) today announced the appointment of Stephen Quake, D.Phil., to its Board of Directors as an independent director.
Dr. Quake is a distinguished scientist, inventor, and entrepreneur who has made foundational contributions across diverse fields, including single molecule biophysics, microfluidics, single cell analysis, genom...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Levi & Korsinsky Notifies Avantor, Inc. (AVTR) Investors - Lead Plaintiff Deadline on December 29, 2025
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - If you suffered a loss on your Avantor, Inc. (NYSE: AVTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/avantor-inc-lawsuit-submission-form?prid=176444&wire=5&utm_campaign...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
The Gross Law Firm Reminds Baxter International, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - BAX
News Preview
NEW YORK, Nov. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. (NYSE: BAX).
Shareholders wh...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
Lost Money on aTyr Pharma, Inc.(ATYR)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
News Preview
NEW YORK, Nov. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of aTyr Pharma, Inc. (NASDAQ: ATYR).
Shareholders who purc...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
The Gross Law Firm Notifies Shareholders of Avantor, Inc.(AVTR) of a Class Action Lawsuit and an Upcoming Deadline
News Preview
NEW YORK, Nov. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Avantor, Inc. (NYSE: AVTR).
Shareholders who purchased...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Immunotherapeutics Class Action: The Gross Law Firm Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX
News Preview
NEW YORK, Nov. 10, 2025 The Gross Law Firm issues the following notice to shareholders of MoonLake Immunotherapeutics (NASDAQ: MLTX).
Shareholders who purchased...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
10.11.2025
ISIN: US9286611077
VolitionRX Ltd
VNRX
LISTED
XASE
VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update
News Preview
Conference call to take place on Friday, November 14 at 8:30 a.m. U.S. Eastern Time
HENDERSON, Nev., Nov. 10, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announces that it will host a conference call on Friday, November 14 at...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Investors in Cytokinetics, Incorporated Should Contact The Gross Law Firm Before November 17, 2025 to Discuss Your Rights - CYTK
News Preview
NEW YORK, Nov. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK).
Shareholders...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Investors who lost money on Lantheus Holdings, Inc.(LNTH) should contact The Gross Law Firm about pending Class Action - LNTH
News Preview
NEW YORK, Nov. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH).
Shareholders wh...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
DexCom, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before December 26, 2025 to Discuss Your Rights - DXCM
News Preview
NEW YORK, Nov. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM).
Shareholders who purchased...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Avantor® Appoints Mary Blenn as Executive Vice President and Chief Operating Officer
News Preview
RADNOR, Pa., Nov. 10, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced that Mary Blenn has been appointed to the newly created role of Executive Vice Presiden...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: CA62857B1094
Mynd Life Sciences Inc.
MYND
LISTED
CSE
Mynd.ai's Promethean brand Forges Strategic Relationship with Augment Me to Advance AI-Powered Learning
News Preview
SEATTLE, Nov. 10, 2025 /PRNewswire/ -- Mynd.ai, Inc ("Mynd" or the Company) (NYSE American: MYND) today announced that its subsidiary, Promethean, a leading global tech company, is proud to announce a strategic relationship with Augment Me Inc., a trailblazer in artificial intelligence solutions designed to enhan...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Tandem Mobi Receives FDA Clearance for Use with Android Smartphones
News Preview
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Android version of the Tandem Mobi mobile app.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202511107994...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Lost Money on Baxter International, Inc. (BAX)? Join Class Action Before December 15, 2025 - Contact Levi & Korsinsky
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - If you suffered a loss on your Baxter International, Inc. (NYSE: BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=176438...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US1404752032
Sonida Senior Living Inc
SNDA
LISTED
NYSE
Sonida Senior Living Announces Third Quarter 2025 Results
News Preview
Sonida Senior Living, Inc. (the “Company,” “Sonida,” “we,” “our,” or “us”) (NYSE: SNDA), a leading owner, operator and investor of senior housing communities, today announced its results for the third quarter ended September 30, 2025.
“In the third quarter, total portfolio community NOI grew approximately 21%, driven by solid rent growth and stro...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: CA25253X2077
DiaMedica Therapeutics, Inc.
DMAC
LISTED
NASDAQ
DiaMedica Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
News Preview
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced that Rick Pauls, President and CEO, will participate in the Jefferies Global Healthcare Conference in London, taking place November 17-20...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US40131M1099
Guardant Health Inc
GH
LISTED
NASDAQ
Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the expansion of its Guardant Reveal® blood test to include late-stage therapy response monitoring for patients with solid tumors. Guardant Reveal tracks more than 20,000 epigenomic (methylation) signals to measure changes in circulating tumor DNA (ctDNA) lev...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter from Absolute Total Care Offers Health Insurance in South Carolina in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable plans from Ambetter from Absolute Total Care statewide
COLUMBIA, S.C., Nov. 10, 2025 /PRNewswire/ -- Ambetter from Absolute Total Care, a product offered by a Centene Corporation (NYSE: CNC) company, a lead...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US28036F1057
Edgewise Therapeutics Inc
EWTX
LISTED
NASDAQ
Edgewise Therapeutics Announces Appointment of Michael Nofi as Chief Financial Officer, and the Retirement of Current CFO, R. Michael Carruthers
News Preview
BOULDER, Colo., Nov. 10, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions, today announced the appointment of Michael Nofi, as Chief Financial Officer (CFO), ef...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US0327241065
AnaptysBio Inc
ANAB
LISTED
NASDAQ
Anaptys Announces Phase 2 Trial of Rosnilimab Did Not Meet Primary or Secondary Endpoints at Week 12 in Moderate-to-Severe Ulcerative Colitis
News Preview
SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that investigational rosnilimab was safe and well tolerated but did not meet the primary endpoint of mean change from baseline in modified Mayo Score (mMS) o...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US46266A1097
IRadimed Corp
IRMD
LISTED
NASDAQ
IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026
News Preview
Recognized for Exceptional Revenue Growth, Financial Stability, and Stock Performance Recognized for Exceptional Revenue Growth, Financial Stability, and Stock Performance...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US1920051067
Codexis Inc
CDXS
LISTED
NASDAQ
Codexis Announces Signing of Lease for GMP Manufacturing Facility
News Preview
REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it has signed a lease for a 34,000 square foot GMP manufacturing facility in Hayward, California....
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US29415V1098
Envoy Medical, Inc.
COCH
LISTED
NASDAQ
Envoy Medical Reports Third Quarter 2025 Financial and Operational Results
News Preview
Transformational quarter puts Envoy Medical in significantly better position as it eliminated $32 million of debt, strengthened its balance sheet, and further expanded its patent portfolio; In addition, subsequent to quarter end, the Company received FDA approval to expand its pivotal clinical trial to the final stage, restarted enrollment, and suc...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US3444374058
Fonar Corp
FONR
LISTED
NASDAQ
Fonar Announces Financial Results For The 1st Quarter of Fiscal 2026
News Preview
Cash and cash equivalents decreased 4% to $54.3 million at September 30, 2025 as compared to the fiscal year-ended June 30, 2025.Total Revenues - Net increased by 4% to $26.0 million for the quarter ended September 30, 2025 versus the corresponding quarter one year earlier.Income from Operations decreased 30% to $3.2 million for the quarter ended S...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Humana Foundation Pledges $500,000 to Meet Surge in Demand for Food
News Preview
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 44 years, today announced $500,000 in new investments to support food banks and nutrition programs in four states. The funding will help address urgent needs in communities where the loss of food assistance for nearly 42 million Americans, have intensified food in...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US87427V1035
Talkspace Inc
TALK
LISTED
NASDAQ
Talkspace Launches “Chapters” — A Comprehensive Program Supporting Women’s Mental Health Across Every Stage of Life
News Preview
Talkspace, a leading online behavioral health company, today announced the launch of Chapters by Talkspace, a new clinical program designed to address the unique mental health and wellness needs of women throughout their lifespan.
Chapters delivers tailored care across women’s life stages, offering personalized treatment pathways that adapt to in...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process
News Preview
Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today commented on the recent filing of amendments to the merger agreement in connection with the proposed sale of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) to Alcon Inc. (“Alcon”) (NYSE: ALC).
Neal C. Bradsher, Founder and President of Broadwood, said...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US89680M1018
TriSalus Life Sciences, Inc.
TLSI
LISTED
NASDAQ
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Uterine Fibroids on November 12, 2025
News Preview
TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid tumors, announced today that it will host a virtual key opinion leader (KOL) event on Wednesday, November 12, 2025 at 10:00 AM ET featuri...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US14167L1035
CareDx Inc
CDNA
LISTED
NASDAQ
CareDx to Participate in Upcoming Investor Conferences
News Preview
CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in the following investor conferences:
Stephen...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US56600D1072
Maravai LifeSciences Holdings Inc
MRVI
LISTED
NASDAQ
Maravai LifeSciences Announces November 2025 Investor Conference Schedule
News Preview
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of November.
On November 12, 2025, at 10:00 a.m. EST, Raj Asarpota, Chief Financial Officer, will participate in a fireside chat...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US7140461093
Revvity Inc
RVTY
LISTED
NYSE
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities
News Preview
Revvity, Inc. (NYSE: RVTY), today announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software solutions that support analytical characterization and molecular design across pharmaceutical and material sciences end markets. This acquisition expands the breadth and depth of Revvity Signals’ solu...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: CH0499880968
ADC Therapeutics SA
ADCT
LISTED
NYSE
ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update
News Preview
Continued progress across LOTIS-7 with updated data anticipated in 2025 and LOTIS-5 with topline data expected in 1H 2026
Updated data from Phase 2 IIT of ZYNLONTA®
plus rituximab in patients with r/r follicular lymphoma presented at the 22nd...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US70465T1079
PDS Biotechnology Corp
PDSB
LISTED
NASDAQ
PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical Activity of PDS0101 and PDS01ADC Presented at SITC 2025
News Preview
PRINCETON, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced positive clinical and translational data presented at the 2025 Society for Immunotherapy of Ca...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US62855J1043
Myriad Genetics Inc
MYGN
LISTED
NASDAQ
Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs
News Preview
Myriad Genetics expanded MyRisk® Hereditary Cancer Test to include genes referenced in national oncology guidelines....
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH INVESTOR NOTICE: Molina Healthcare, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
News Preview
San Diego, California--(Newsfile Corp. - November 10, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, inclusive (the "Class Period"), have until Tuesday, December 2, 2025 to seek appointment as lead plain...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US68622V1061
Organon & Co
OGN
LISTED
NYSE
Organon Reports Results for the Third Quarter Ended September 30, 2025
News Preview
Organon (NYSE: OGN) today announced its results for the third quarter ended September 30, 2025.
“I am humbled to be working alongside our talented team during this pivotal time for Organon,” said Joe Morrissey, Organon’s Interim Chief Executive Officer. “We are harnessing the company's many strengths, including a diverse portfolio that we expect...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US81727U1051
Senseonics Holdings Inc
SENS
LISTED
XASE
Senseonics Holdings, Inc. to Participate in the Stifel 2025 Healthcare Conference
News Preview
GERMANTOWN, Md., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Stifel 2025 Healthcare Co...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US46333X1081
Ironwood Pharmaceuticals Inc
IRWD
LISTED
NASDAQ
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance
News Preview
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today reported its third quarter 2025 results and recent business performance.
“LINZESS delivered a strong third-quarter performance, driven by accelerated d...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US15117B1035
Celldex Therapeutics, Inc.
CLDX
LISTED
NASDAQ
Celldex Announces Appointment of Teri Lawver as Chief Commercial Officer
News Preview
HAMPTON, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ: CLDX) today announced the appointment of Teri Lawver as Senior Vice President, Chief Commercial Officer. Ms. Lawver is an accomplished global healthcare executive with 30 years of strategic, commercial launch and operating P&L leadership across the biopharmaceutical, medical de...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US92915B1061
Voyager Therapeutics Inc
VYGR
LISTED
NASDAQ
Voyager Reports Third Quarter 2025 Financial and Operating Results
News Preview
- Momentum building around tau: expect VY7523 clinical data and VY1706 clinical entry in 2026 - ...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US92915B1061
Voyager Therapeutics Inc
VYGR
LISTED
NASDAQ
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia
News Preview
CAMBRIDGE, United Kingdom and LEXINGTON, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Transition Bio, a drug discovery company focused on unlocking traditionally “undruggable” targets by leveraging biomolecular condensates, and Voyager Therapeutics (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: DE000BAY0017
Bayer AG
BAYN
LISTED
XETR
Bayer Launches “Science Delivers” Campaign Celebrating the Transformative Power of Science
News Preview
Today, on World Science Day, Bayer is proud to launch its “Science Delivers” campaign, a nationwide initiative celebrating how science delivers answers, hope, and progress for all Americans—every day, in the moments that matter most.
From the medicine that keeps us healthy to the technology that connects and helps feed us, to the innovations tha...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US38942Q2021
CalciMedica Inc
CALC
LISTED
NASDAQ
CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025
News Preview
Treatment with Auxora significantly reduced IL-17–related inflammation in both kidney and lung, significantly increased glomerular filtration rate (GFR), and decreased renal injury in a rat model of AKI
Findings reinforce the mechanistic rationale for Auxora as a potential treatment for severe AKI with respiratory f...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US04216R1023
Armata Pharmaceuticals, Inc.
ARMP
LISTED
XASE
Armata Pharmaceuticals Announces Formal Commissioning of State-of-the-Art cGMP Phage Manufacturing Facility in Los Angeles, California
News Preview
LOS ANGELES, Nov. 10, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US04272N1028
Arrivent Biopharma Inc
AVBP
LISTED
NASDAQ
ArriVent BioPharma Reports Third Quarter 2025 Financial Results
News Preview
NEWTOWN SQUARE, Pa., Nov. 10, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (“Company” or “ArriVent”) (Nasdaq: “AVBP”), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today reported financial results for the third quarter ended September 30, 2025, and highlighted recent...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: CH0334081137
CRISPR Therapeutics AG
CRSP
LISTED
NASDAQ
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
News Preview
-Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) Scientific Sessions and simultaneously published in The New England Journal of Medicine-...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US35104E1001
4D Molecular Therapeutics Inc
FDMT
LISTED
NASDAQ
4DMT Reports Third Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
News Preview
EMERYVILLE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today reported Q3 2025 financial results...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US5588681057
Madrigal Pharmaceuticals Inc
MDGL
LISTED
NASDAQ
Madrigal Presents New Data Demonstrating Rezdiffra® (resmetirom) Significantly Improved Multiple Noninvasive Imaging Tests and Biomarkers in Patients with Compensated MASH Cirrhosis
News Preview
CONSHOHOCKEN, Pa., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced positive two-year data from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US28659T2006
Elite Pharmaceuticals, Inc.
ELTP
LISTED
OTC
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025
News Preview
Financials for Second Quarter of Fiscal Year 2026 Ended September 30, 2025 will be released on Friday, November 14, 2025Northvale, New Jersey--(Newsfile Corp. - November 10, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced today th...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: JP3475350009
Daiichi Sankyo Co Ltd
45680
LISTED
XJPX
DS3610 Enters Clinical Development in Patients with Advanced Solid Tumors as First STING Agonist ADC in Industry-Leading ADC Portfolio of Daiichi Sankyo
News Preview
The first patient has been dosed in a first-in-human phase 1 trial evaluating DS3610 in patients with advanced, metastatic or unresectable solid tumors.
DS3610 is an investigational STING agonist antibody drug conjugate (ADC) containing an immunomodulatory payload discovered by Daiichi Sankyo (TSE:4568).
Despite the availability of various can...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US0373261058
AN2 Therapeutics Inc
ANTX
LISTED
NASDAQ
AN2 Therapeutics Announces Research Collaboration With GSK to Advance Boron-Based LeuRS-Inhibitors Targeting Tuberculosis (TB)
News Preview
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics through its boron chemistry platform, today announced a collaboration agreement with the global biopharma company GSK to develop new therapies for tuberculosis (TB). As part of this effort, the Gates Foundation will provide a third year o...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US30063P1057
Exact Sciences Corp
EXAS
LISTED
NASDAQ
Exact Sciences Announces Expiration of the HSR Waiting Period for Exclusive License to Freenome’s Blood-Based Colorectal Cancer Screening Tests
News Preview
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) for its previously announced license agreement with Freenome. Under the agreement, the Company acquired exclusive rights in the U...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: VGG111961055
Biohaven Ltd.
BHVN
LISTED
NYSE
Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments
News Preview
NEW HAVEN, Conn., Nov. 10, 2025 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today reported financia...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: KYG0146B1032
Akeso, Inc.
9926
LISTED
HKSE
Akeso Announces First Patient Dosed in Phase I Trial of Personalized mRNA Vaccine AK154 as Monotherapy or in Combination with Cadonilimab or Ivonescimab for Adjuvant Treatment of Pancreatic Cancer
News Preview
HONG KONG, Nov. 10, 2025 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926. HK) is pleased to announce that the first patient has been dosed in a Phase I clinical trial evaluating the personalized mRNA vaccine AK154. This trial is investigating AK154 both as a monotherapy and as a combination with the company's first-in-cl...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
